UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032079
Receipt number R000036501
Scientific Title Study on safety and efficacy of pinhole contact lens to correct presbyopia with both eyes wearing
Date of disclosure of the study information 2018/04/05
Last modified on 2018/10/03 17:18:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on safety and efficacy of pinhole contact lens to correct presbyopia with both eyes wearing

Acronym

Safety and efficacy of pinhole contact lens with both eyes wearing

Scientific Title

Study on safety and efficacy of pinhole contact lens to correct presbyopia with both eyes wearing

Scientific Title:Acronym

Safety and efficacy of pinhole contact lens with both eyes wearing

Region

Japan


Condition

Condition

myopia or myopic astigmatism with presbyopia corrected good visual acuity

Classification by specialty

Ophthalmology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of refractive and presbyopic correction with the pinhole contact lens(both eyes).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Distance and near visual acuities with or without the pinhole contact lens(both eyes).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Wearing a pinhole contact lens with both eyes

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) 45 years old and over
2) Patients with myopia and myopic astgmatism whose spherical equivalent of subjective refraction is between -1 and -9 dioptor as well as whose corrected visual acuity of 1.0 and pver
3) The astigmatism less than half of the spherical power
4) The patients whose both eyes can be observed and wearing
5) The patients who can come for examination on specified days
6) The patients who can wear pinhole contact lens daily for 3-8 hours
7) Soft CLs users
8) The patients who understand instructions and the explanation of the doctor, and can give a conscent

Key exclusion criteria

1) multifocal CLs users
2) toric CLs users
3) usershard CLs users
4) Subjects who cannot wear a contact lens
5) Corneal endothelial cell density < 2000/mm2
6) Corneal diameter < 10mm
7) Subjects who have ocular diseases affecting visual function except for refractive error and presbyoia
8) A pregnant woman, a woman nursing or woman with the plan of the pregnancy
9)The person who connot follow the instructions of the ophthalmologist
10) Extremely nervous persons
11) Person who are not able to undergo examinations
12) In addition, the person who are judged unsuitable to use pinhole contactlens by ophthalmologists



Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Miki Iwasaki

Organization

RYOGOKU EYE CLINIC

Division name

Hospital Director

Zip code


Address

4-33-12, Ryogoku, Sumida-ku, Tokyo, JAPAN

TEL

03-5600-6886

Email

mikiwasaki@aol.com


Public contact

Name of contact person

1st name
Middle name
Last name Miki Iwasaki

Organization

RYOGOKU EYE CLINIC

Division name

Hospital Director

Zip code


Address

4-33-12, Ryogoku, Sumida-ku, Tokyo, JAPAN

TEL

03-5600-6886

Homepage URL


Email

mikiwasaki@aol.com


Sponsor or person

Institute

RYOGOKU EYE CLINIC
Hospital Director

Institute

Department

Personal name



Funding Source

Organization

own supply

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

no

Name of secondary funder(s)

no


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

両眼眼科クリニック


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 08 Day

Date of IRB


Anticipated trial start date

2018 Year 04 Month 15 Day

Last follow-up date

2018 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2018 Year 08 Month 31 Day

Date analysis concluded

2018 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2018 Year 04 Month 03 Day

Last modified on

2018 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036501


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name